Ratio Therapeutics Appoints Marcel Reichen as Chief Strategy Officer

Ratio Therapeutics; Marcel Reichen; Chief Strategy Officer; radiopharmaceuticals; oncology; radioligand therapy; pharmaceutical industry; cancer treatment; strategic growth; precision oncology

Eli Lilly and Nvidia to Build Pharma’s Largest AI Supercomputer for Drug Discovery

Eli Lilly; Nvidia; supercomputer; AI; drug discovery; Blackwell Ultra GPU; clinical trials; biomedical foundation models; pharmaceutical industry; high-performance computing

Recent Law Expands Orphan Drug Protections, Shielding Blockbusters from Medicare Price Negotiations

orphan drug exclusion; Medicare negotiation; One Big Beautiful Bill; Keytruda; Opdivo; Inflation Reduction Act; OBBBA; drug pricing; Congress; pharmaceutical industry